Brightgene Bio-medical Technology Co (SHSE:688166) Dividend Payout Ratio : 0.00 (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Brightgene Bio-medical Technology Co Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Brightgene Bio-medical Technology Co's Dividend Payout Ratio for the months ended in Mar. 2025 was 0.00.

The historical rank and industry rank for Brightgene Bio-medical Technology Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:688166' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15 Med: 0.22 Max: 0.26
Current: 0.24

During the past 9 years, the highest Dividend Payout Ratio of Brightgene Bio-medical Technology Co was 0.26. The lowest was 0.15. And the median was 0.22.

SHSE:688166's Dividend Payout Ratio is ranked better than
77.21% of 136 companies
in the Biotechnology industry
Industry Median: 0.46 vs SHSE:688166: 0.24

As of today (2025-04-23), the Dividend Yield % of Brightgene Bio-medical Technology Co is 0.23%.

During the past 9 years, the highest Trailing Annual Dividend Yield of Brightgene Bio-medical Technology Co was 0.66%. The lowest was 0.13%. And the median was 0.32%.

Brightgene Bio-medical Technology Co's Dividends per Share for the months ended in Mar. 2025 was ¥0.00.

During the past 12 months, Brightgene Bio-medical Technology Co's average Dividends Per Share Growth Rate was -15.80% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 4.60% per year.

During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Brightgene Bio-medical Technology Co was 11.60% per year. The lowest was 4.60% per year. And the median was 8.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Brightgene Bio-medical Technology Co Dividend Payout Ratio Historical Data

The historical data trend for Brightgene Bio-medical Technology Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brightgene Bio-medical Technology Co Dividend Payout Ratio Chart

Brightgene Bio-medical Technology Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dividend Payout Ratio

Get a 7-Day Free Trial

0.22

0.15

0.23

0.26

0.22

Brightgene Bio-medical Technology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Dividend Payout Ratio	Get a 7-Day Free Trial															-	0.83	-	-	-

Competitive Comparison of Brightgene Bio-medical Technology Co's Dividend Payout Ratio

For the Biotechnology subindustry, Brightgene Bio-medical Technology Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brightgene Bio-medical Technology Co's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brightgene Bio-medical Technology Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Brightgene Bio-medical Technology Co's Dividend Payout Ratio falls into.

Save Embed

;

Save Embed

;

Brightgene Bio-medical Technology Co Dividend Payout Ratio Calculation

Brightgene Bio-medical Technology Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2024 )	/	EPS without NRI (A: Dec. 2024 )
	=	0.096	/	0.43
	=	0.22

Brightgene Bio-medical Technology Co's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	0.031
	=	0.00

Brightgene Bio-medical Technology Co (SHSE:688166) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Brightgene Bio-medical Technology Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Brightgene Bio-medical Technology Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Brightgene Bio-medical Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brightgene Bio-medical Technology Co Ltd (SHSE:688166) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xinghu Street, Industrial Park, Building C25-C28, Bio-Nano Park, No. 218, Suzhou, CHN, 215123

Website

http://www.bright-gene.com

Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.

Brightgene Bio-medical Technology Co Headlines

No Headlines